CCR7 Expressing Mesenchymal Stem Cells Potently Inhibit Graft-versus-Host Disease by Spoiling the Fourth Supplemental Billingham’s Tenet

The clinical acute graft-versus-host disease (GvHD)-therapy of mesenchymal stem cells (MSCs) is not as satisfactory as expected. Secondary lymphoid organs (SLOs) are the major niches serve to initiate immune responses or induce tolerance. Our previous study showed that CCR7 guide murine MSC line C3H...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hong, Jiang, Yan-Ming, Sun, Yan-Feng, Li, Ping, Dang, Rui-Jie, Ning, Hong-Mei, Li, Yu-Hang, Zhang, Ying-Jie, Jiang, Xiao-Xia, Guo, Xi-Min, Wen, Ning, Han, Yan, Mao, Ning, Chen, Hu, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280136/
https://www.ncbi.nlm.nih.gov/pubmed/25549354
http://dx.doi.org/10.1371/journal.pone.0115720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280136/
https://www.ncbi.nlm.nih.gov/pubmed/25549354
http://dx.doi.org/10.1371/journal.pone.0115720

Ejemplares similares